GLP-1 medical history questions to ask before starting care

A fast intake is not the same as a complete safety review

A GLP-1 clinic can feel simple from the outside: answer questions, upload payment details, and wait for a decision. The safer comparison is whether a licensed clinician has enough medical-history context to decide whether any treatment discussion is appropriate. Use this checklist to prepare for that conversation; do not use it to self-screen, diagnose yourself, or decide whether to start, stop, or change medication.

• Write down your diagnoses, recent procedures, allergies, prior medication reactions, and current symptoms before the visit.
• Bring recent labs, pharmacy records, and specialist notes if they could affect weight-management decisions.
• Ask who reviews the history and how they handle missing, unclear, or high-risk answers.
• Pause before paying if the program treats a short marketing questionnaire as a full clinical evaluation.

Ask how contraindications and family history are reviewed

FDA prescribing information for Wegovy and Zepbound lists contraindications involving a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, as well as serious hypersensitivity to the medication or its ingredients. You do not need to interpret a label by yourself, but you should expect the clinician to ask directly about relevant personal and family history before making treatment decisions.

• Ask what family-history questions the clinician needs answered before considering GLP-1 treatment.
• Ask how the provider handles uncertain family history, thyroid nodules, prior allergic reactions, or incomplete records.
• Ask whether the medication name, active ingredient, and product form are documented in your chart.
• If an online program skips family-history and allergy questions, ask how a clinician can complete the review safely.

Discuss pancreas, gallbladder, kidney, stomach, and eye history

FDA labeling for GLP-1 weight-loss medications includes warnings and precautions that a clinician may need to weigh against a person's history, current symptoms, other medications, and monitoring plan. Relevant topics can include pancreatitis, gallbladder disease, kidney problems related to dehydration, severe gastrointestinal disease, diabetic retinopathy in people with type 2 diabetes, and symptoms that need prompt evaluation. The point is not to memorize every label warning; it is to make sure the clinician has the facts.

• Tell the clinician about prior pancreatitis, gallbladder disease, severe reflux, severe constipation, gastroparesis, kidney problems, or dehydration episodes.
• Tell the clinician if you have diabetes, use glucose-lowering medication, or have a history of diabetic retinopathy or vision changes.
• Ask what symptoms should be handled through the clinic, what should go to local urgent care, and what should be reported to FDA MedWatch.
• Ask whether baseline labs, vitals, or specialist records are needed before any prescribing decision.

Separate weight-history context from eligibility claims

NIDDK explains that prescription weight-management medicines should be used under health care professional guidance and that people should talk with a professional about other medicines, warnings, side effects, and pregnancy plans. A credible provider should collect weight history, prior treatment attempts, metabolic conditions, nutrition constraints, and goals without promising eligibility, access, or a specific outcome before clinician review.

• Ask what information the clinician uses to decide whether medication, non-medication care, referral, or no treatment is appropriate.
• Ask how the provider handles eating-disorder history, rapid weight changes, prior bariatric surgery, or complex endocrine history.
• Ask whether nutrition, physical activity, sleep, behavioral support, or specialist referral are part of the care plan when needed.
• Be cautious with programs that advertise medication access as the default answer before reviewing your health context.

Pregnancy, fertility, and lactation questions need early routing

Existing GLP-1 labels and patient resources treat pregnancy planning as a clinician-level topic, and NIDDK advises against taking weight-management medication during pregnancy or while planning pregnancy. If pregnancy, fertility treatment, contraception, lactation, or postpartum care may be relevant, ask how the clinic routes that conversation before payment or shipment. This is not a substitute for obstetric, fertility, endocrinology, or primary-care guidance.

• Ask whether the provider screens for pregnancy plans before treatment decisions.
• Ask what records or specialist input are needed if you are trying to conceive, could become pregnant, are postpartum, or are breastfeeding.
• Ask how the provider coordinates with an OB-GYN, fertility specialist, primary care clinician, or endocrinologist.
• Do not rely on a clinic's sales page as contraception, fertility, pregnancy, or lactation advice.

Ask what happens if your history changes after signup

Medical history is not a one-time form. New symptoms, procedures, hospital visits, lab results, pregnancy plans, medication changes, and insurance barriers can all change the care conversation. Before choosing a provider, ask how to update your history, who reviews the update, how quickly urgent messages are handled, and whether local care or specialist care is required for certain issues.

• Ask how to report new abdominal pain, vomiting, dehydration, vision changes, allergic symptoms, pregnancy, surgery plans, or new diagnoses.
• Ask whether the program has after-hours escalation or only routine inbox messaging.
• Ask whether updates are reviewed by the prescribing clinician, a care coordinator, a pharmacist, or another team member.
• Ask for written cancellation and refund terms if clinical review shows the program is not appropriate for you.

What original data would make this decision easier

The strongest future version of this guide would compare real provider intake forms, clinician-review workflows, high-risk escalation policies, local-care referral rules, baseline lab requirements, pharmacy safety checks, cancellation terms, and average review timelines. Until that data exists, use medical-history completeness as a trust signal when comparing online and local GLP-1 options.